
|Articles|April 13, 2020
Glaucoma 360: Glaucoma devices update with Victor Chan, MB, MS (Santen Inc)
Author(s)Alex Delaney-Gesing
Advertisement
Victor Chan, MBA, MS, director of U.S. Surgical Device Commercial Marketing at Santen, Inc., offers insight on the Glaucoma Devices panel discussion regarding new innovations and diagnostic devices during Glaucoma 360 2020 in San Francisco, California.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA issues Complete Response Letter to Sydnexis for SYD-101 pediatric myopia treatment
2
Nanoscope Therapeutics releases positive 3-year follow-up data from REMAIN study
3
Proactive strategies and sustained delivery advance glaucoma care
4
STAAR postpones Alcon merger vote, Broadwood calls for removal of board members
5

















































.png)


